-
PLoS Pathogens: Discover new clues for mother-to-child transmission of HIV
Time of Update: 2021-05-08
The results of the study indicate that the circulating mother virus is resistant to bnAb- mediated neutralization, but not resistant to autologous plasma neutralization, which indicates an increased risk of mother-to-child transmission.
-
BMC Medicine: Proper nutrition to reduce malnutrition and obesity in the COVID-19 epidemic
Time of Update: 2021-05-07
Brett Finlay describes the relationship between food insecurity and gut microbiota and DBM , and how this may be exacerbated in the context of the COVID-19 pandemic.
-
The Lancet: herd immunity and vaccines to prevent infection
Time of Update: 2021-05-07
Infection immunity COVID-19In The Lancet , Victoria J Hall and colleagues7 reported the effectiveness of BNT162b2 against SARS-CoV-2 infection through an observational SIREN (SARS-CoV-2 Immunization and Reinfection Assessment) study.
-
A new type of malaria vaccine
Time of Update: 2021-05-07
Preliminary results show that the effectiveness of the R21 vaccine against malaria in young children is as high as 77%, but researchers are still waiting for larger studies.
-
Nature: COVID-19 vaccine and children: five questions at the beginning of the trial
Time of Update: 2021-05-07
The strong immune response of children means that they are more likely to have a fever after vaccination than adults, so researchers need to strike a balance between triggering a strong immune response and minimizing side effects.
-
New England: SARS-CoV-2 variant breakthrough infection
Time of Update: 2021-05-07
During this critical period, the research supports the need to maintain a multi-layered mitigation strategy, including serial testing of asymptomatic patients, public release and analysis of vaccination and infection databases, and SARS-CoV obtained from various high-risk groups -2 Rapid sequencing of RNA.
-
BMJ: How much do you know about the Covaxin vaccine in India: Hastily launched, controversy continues
Time of Update: 2021-05-07
Covaxin was urgently approved on January 3, 2021, although the Phase III clinical trial of Covaxin is still in progress, the phase II study Not yet publishedIn India, the vaccine is currently being administered to people over 60 and over 45 with co-morbidities and health workers.
-
Latest, quick look!
Time of Update: 2021-05-07
Which vaccine to choose for patients with skin diseases?At present, the new crown vaccines on the market in my country have undergone rigorous clinical research, and their safety and effectiveness have been fully verified.
-
BMJ: The new coronary pneumonia has been epidemic for so long, do you have a spectrum about whether drug prevention is effective?
Time of Update: 2021-05-07
In a real-time system review and online meta-analysis, some researchers compared the effects of covid-19 drug prevention.
The included studies are randomized trials of people at risk of COVID-19 who receive prevention or not (standard care or placebo).
-
Nat Com: Be wary of diphtheria antimicrobial resistance threatening the world again
Time of Update: 2021-05-07
The diphtheria vaccine is designed to neutralize the toxin, so any genetic variation that changes the structure of the toxin may affect the effectiveness of the vaccine.
-
Current Commentary: "You don't need to wear a mask when you drink Baiyunshan Isatis root from the mouth"?
Time of Update: 2021-05-07
If Banlangen can prevent the new crown, then there will be no such thing as a series of vaccine companies such as Kexing and Beijing Biological.
-
Nat Med: Take precautions and prepare for the future epidemic
Time of Update: 2021-05-07
However, whether in terms of health or economics, the real impact of COVID-19 may exceed the acute phase of the pandemic, opening a window of opportunity for lasting change while the virus is still in people’s minds.
-
BMJ: After the first dose of AstraZeneca or Pfizer vaccine, the number of infections dropped by 65%
Time of Update: 2021-05-07
The results of the two preprinted studies showed that the level of protection of the two doses of Pfizer vaccine against covid-19 was similar to the level of previous SARS-CoV-2 infections.
-
Science Translational Medicine: COVID-19 patients should beware of cardiomyocyte damage
Time of Update: 2021-05-07
These significant cytopathic characteristics of cardiomyocytes provide us with a platform for discovering potential treatments for SARS-CoV-2 induced heart damage, and raise concerns about the long-term consequences of COVID-19 in asymptomatic and severe cases .
-
BMJ: Covid-19: What do we know about the airborne transmission of SARS-CoV-2?
Time of Update: 2021-05-07
Although covid-19 may spread the virus through aerosols, it is not the main route of SARS-CoV-2 transmission.
Although covid-19 may spread the virus through aerosols, it is not the main route of SARS-CoV-2 transmission.
-
Stem Cells Dev: Research and analysis on the safety and effectiveness of allogeneic bone marrow mesenchymal stem cells exosomes in the treatment of severe COVID-19
Time of Update: 2021-05-07
Recently, researchers from the United States conducted a prospective non-random open-label cohort study to explore the safety and effectiveness of allogeneic bone marrow mesenchymal stem cell exosomes (ExoFlo™) in the treatment of severe COVID-19.
gov/32380908/" target="_blank" rel="noopener">Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19 .
-
BMJ: Post-covid-19 syndrome needs attention
Time of Update: 2021-05-07
MACE=Major adverse cardiovascular events Cardiovascular eventsOn August 31, 2020, the mortality, readmission rate and multiple organ dysfunction rate of covid-19 patients and matched control patients discharged from the hospital in England were stratified by individual factors.
-
BMJ: How will the covid-19 vaccine safety issue affect vaccine confidence?
Time of Update: 2021-05-07
Will the UK decide to provide an alternative Oxford/AstraZeneca covid-19 vaccine for people under 30 based on safety signals and the impact of vaccination?After reviewing the 19 deaths and 79 blood clotting cases reported after vaccination, the United Kingdom recommended that people under the age of 30 provide a vaccine that replaces the Oxford/AstraZeneca ChAdOx1 novel coronavirus vaccine (AZD1222) as a preventive measure.
-
JACC: The impact of the new coronary pneumonia pandemic on the diagnosis, treatment and prognosis of ST-segment elevation myocardial infarction
Time of Update: 2021-05-07
In recent days, India’s out-of-control epidemic, the collapse of the medical system, lack of oxygen, and the burning of corpses in the street remind us that the new crown epidemic is still not over. T
-
BMJ: To curb the spread of COVID-19, intervention based on symptoms and cases is not enough
Time of Update: 2021-05-07
Improve the effectiveness of testing, tracking and quarantine in a limited public health systemOriginal source:Smith LE, Potts HWW, Amlôt R, Fear NT, Michie S, Rubin GJ.